World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
46
Citations
10270
World Ranking
4592
National Ranking
56

Carlota Dobaño publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Carlota Dobaño sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 252 publications — 52nd percentile

52% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Carlota Dobaño D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Carlota Dobaño sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 46 D-Index — 8th percentile

8% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Carlota Dobaño is affiliated with the University of Barcelona in Spain and has established a research profile primarily in the domain of Medicine. Their work spans several focused subfields, including Infectious Diseases, Public Health, Environmental and Occupational Health, Immunology, Health, Toxicology and Mutagenesis, and Neurology.

The main research topics covered by their publications emphasize SARS-CoV-2 and COVID-19 Research, with substantial contributions to COVID-19 Clinical Research Studies and Malaria Research and Control. Other notable areas include SARS-CoV-2 detection and testing, Long-Term Effects of COVID-19, the Complement system in diseases, and COVID-19 epidemiological studies.

Carlota Dobaño has published numerous papers, several of which have gained significant attention. Recent examples include:

  • Spread of a SARS-CoV-2 variant through Europe in the summer of 2020, 2021, published in Nature
  • Seroprevalence of antibodies against SARS-CoV-2 among health care workers in a large Spanish reference hospital, 2020, published in Nature Communications
  • The effect of early treatment with ivermectin on viral load, symptoms and humoral response in patients with non-severe COVID-19: A pilot, double-blind, placebo-controlled, randomized clinical trial, 2021, published in EClinicalMedicine
  • Seven-month kinetics of SARS-CoV-2 antibodies and role of pre-existing antibodies to human coronaviruses, 2021, published in Nature Communications
  • Improving Vaccine-Induced Immunity: Can Baseline Predict Outcome?, 2020, published in Trends in Immunology

The frequent co-authors collaborating with Carlota Dobaño include Gemma Moncunill, Ruth Aguilar, Marta Vidal, Alfons Jiménez, and Luís Izquierdo.

Regarding publication venues, Carlota Dobaño has contributed extensively to journals and repositories such as bioRxiv (Cold Spring Harbor Laboratory), Frontiers in Immunology, BMC Medicine, Research Square, and Scientific Reports.

Best Publications

  • Acquired immunity to malaria.

    Denise L. Doolan;Carlota Dobaño;J. Kevin Baird

  • Genetic Diversity and Protective Efficacy of the RTS,S/AS01 Malaria Vaccine

    Daniel E Neafsey;Michal Juraska;Trevor Bedford;David Benkeser

  • Seroprevalence of antibodies against SARS-CoV-2 among health care workers in a large Spanish reference hospital.

    Alberto L. Garcia-Basteiro;Alberto L. Garcia-Basteiro;Gemma Moncunill;Marta Tortajada;Marta Vidal

  • Spread of a SARS-CoV-2 variant through Europe in the summer of 2020.

    Emma B. Hodcroft;Emma B. Hodcroft;Emma B. Hodcroft;Moira Zuber;Sarah Nadeau;Sarah Nadeau;Timothy G. Vaughan;Timothy G. Vaughan

  • Identification of Plasmodium falciparum antigens by antigenic analysis of genomic and proteomic data.

    Denise L. Doolan;Scott Southwood;Daniel A. Freilich;John Sidney

  • The effect of early treatment with ivermectin on viral load, symptoms and humoral response in patients with non-severe COVID-19: A pilot, double-blind, placebo-controlled, randomized clinical trial.

    Carlos Chaccour;Carlos Chaccour;Carlos Chaccour;Aina Casellas;Andrés Blanco-Di Matteo;Iñigo Pineda

  • Cytoadherence characteristics of Plasmodium falciparum-infected erythrocytes from Malawian children with severe and uncomplicated malaria.

    Stephen J. Rogerson;Rodney Tembenu;Carlota Dobaño;Sabrina Plitt

  • An Autopsy Study of Maternal Mortality in Mozambique: The Contribution of Infectious Diseases

    Clara Menéndez;Cleofé Romagosa;Cleofé Romagosa;Mamudo R Ismail;Carla Carrilho

  • Relation between circulating CC16 concentrations, lung function, and development of chronic obstructive pulmonary disease across the lifespan: a prospective study.

    Stefano Guerra;Stefano Guerra;Marilyn Halonen;Monica M. Vasquez;Amber Spangenberg

  • Challenges and strategies for developing efficacious and long-lasting malaria vaccines

    James G. Beeson;James G. Beeson;James G. Beeson;Liriye Kurtovic;Liriye Kurtovic;Carlota Dobaño;D. Herbert Opi;D. Herbert Opi

  • Concentration and avidity of antibodies to different circumsporozoite epitopes correlate with RTS,S/AS01E malaria vaccine efficacy.

    Carlota Dobaño;Carlota Dobaño;Hèctor Sanz;Hermann Sorgho;David Dosoo

  • Intermittent Preventive Treatment for Malaria Control Administered at the Time of Routine Vaccinations in Mozambican Infants: A Randomized, Placebo-Controlled Trial

    Eusebio Macete;Pedro Aide;John J. Aponte;Sergi Sanz

  • Seven-month kinetics of SARS-CoV-2 antibodies and role of pre-existing antibodies to human coronaviruses.

    Natalia Ortega;Marta Ribes;Marta Vidal;Rocío Rubio

  • Improving Vaccine-Induced Immunity: Can Baseline Predict Outcome?

    John S. Tsang;Carlota Dobaño;Pierre VanDamme;Gemma Moncunill

  • Insights into long-lasting protection induced by RTS,S/AS02A malaria vaccine: further results from a phase IIb trial in Mozambican children.

    Caterina Guinovart;John J. Aponte;Jahit Sacarlal;Pedro Aide

  • Controlled human malaria infection by intramuscular and direct venous inoculation of cryopreserved Plasmodium falciparum sporozoites in malaria-naïve volunteers: effect of injection volume and dose on infectivity rates

    Gloria P Gómez-Pérez;Gloria P Gómez-Pérez;Almudena Legarda;Jose Muñoz;B Kim Lee Sim

  • Highly sensitive and specific multiplex antibody assays to quantify immunoglobulins M, A and G against SARS-CoV-2 antigens.

    Carlota Dobaño;Marta Vidal;Rebeca Santano;Alfons Jimenez

  • Identification of Blood Meals of Phlebotomus perniciosus (Diptera: Psychodidae) in Spain by a Competitive Enzyme-Linked Immunosorbent Assay Biotin/Avidin Method

    María De Colmenares;Montserrat Portús;Jordi Botet;Carlota Dobaño

  • Impact of SARS-CoV-2 Infection on Pregnancy Outcomes: A Population-Based Study.

    Francesca Crovetto;Fàtima Crispi;Elisa Llurba;Elisa Llurba;Rosalia Pascal;Rosalia Pascal

  • Immunogenicity and crossreactivity of antibodies to the nucleocapsid protein of SARS-CoV-2: utility and limitations in seroprevalence and immunity studies.

    Carlota Dobaño;Rebeca Santano;Alfons Jiménez;Marta Vidal

  • RTS,S/AS02A malaria vaccine does not induce parasite CSP T cell epitope selection and reduces multiplicity of infection.

    Sonia Enosse;Carlota Dobaño;Diana Quelhas;John J Aponte

  • Differential Patterns of Human Immunoglobulin G Subclass Responses to Distinct Regions of a Single Protein, the Merozoite Surface Protein 1 of Plasmodium falciparum

    David R. Cavanagh;Carlota Dobaño;Ibrahim M. Elhassan;Kevin Marsh

Frequent Co-Authors

Clara Menéndez
Clara Menéndez University of Barcelona
Pedro L. Alonso
Pedro L. Alonso University of Barcelona
Chetan E. Chitnis
Chetan E. Chitnis Institut Pasteur
Denise L. Doolan
Denise L. Doolan Australian Institute of Tropical Health and Medicine
Quique Bassat
Quique Bassat University of Barcelona
Ivo Mueller
Ivo Mueller Walter and Eliza Hall Institute of Medical Research
Stephen J. Rogerson
Stephen J. Rogerson University of Melbourne
James G. Beeson
James G. Beeson Burnet Institute
Virander S. Chauhan
Virander S. Chauhan International Centre for Genetic Engineering and Biotechnology
Myriam Arévalo-Herrera
Myriam Arévalo-Herrera Caucaseco Scientific Research Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in Immunology, pursuing complementary healthcare degrees can open diverse career opportunities. Many professionals choose to enhance their expertise by enrolling in an accelerated nurse practitioner program, which builds advanced clinical skills in a shorter timeframe, ideal for those with a prior healthcare background.

Those without prior nursing experience may find flexible starting points through online RN programs for non nurses. These programs enable individuals to transition into nursing while balancing other commitments.

For quicker pathways into nursing, exploring absn programs with high acceptance rates is a smart choice. These accelerated programs often have more accessible admissions and focus on condensing the curriculum for faster completion.

Additionally, stepping into the healthcare field through best easiest LPN programs to get into can provide valuable clinical experience and serve as a foundation for further study.

Combining Immunology knowledge with nursing credentials enhances career versatility in research, clinical care, and biotechnology sectors, making these online educational options particularly beneficial.

Best Scientists Citing Carlota Dobaño

Trending Scientists